» Articles » PMID: 12706688

Establishment of an Analyzing Method for a Japanese Encephalitis Virus Neutralization Test in Vero Cells

Overview
Journal Vaccine
Date 2003 Apr 23
PMID 12706688
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

We established a 50% plaque reduction analyzing method of neutralizing antibody for human serum to Japanese encephalitis virus (JEV) in Vero cells, called the '3 points least-squares regression method' (3LSRM). Our method shows a high correlation with the chick embryo cell method (the current standard method for human serum), using the chart method established by the National Institute of Infectious Diseases of Japan, which is an equation made with retrospective data obtained with the 50% plaque reduction method as a standard measurement method for neutralizing antibody titers to JEV. Our new method is much simpler and more reliable than the current method in that it uses an established cell line, Vero cells, and its results are computed by the 3LSRM.

Citing Articles

Persistence of Immune Responses With an Inactivated Japanese Encephalitis Single-Dose Vaccine, JENVAC and Interchangeability With a Live-Attenuated Vaccine.

Vadrevu K, Potula V, Khalatkar V, Mahantshetty N, Shah A, Ella R J Infect Dis. 2019; 222(9):1478-1487.

PMID: 31858116 PMC: 7529014. DOI: 10.1093/infdis/jiz672.


Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010.

Lee E, Cha G, Ju Y, Han M, Lee W, Jeong Y PLoS One. 2016; 11(1):e0147841.

PMID: 26807709 PMC: 4725746. DOI: 10.1371/journal.pone.0147841.


Safety and immunogenicity of a freeze-dried, Vero cell culture-derived, inactivated Japanese encephalitis vaccine (KD-287, ENCEVAC®) versus a mouse brain-derived inactivated Japanese encephalitis vaccine in children: a phase III, multicenter,....

Yun K, Lee H, Kang J, Eun B, Kim Y, Kim K BMC Infect Dis. 2015; 15:7.

PMID: 25567119 PMC: 4296691. DOI: 10.1186/s12879-014-0744-4.


Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine.

Park H, Shim S, Lee E, Cho W, Park S, Jeon H Hum Vaccin Immunother. 2014; 10(5):1181-6.

PMID: 24614530 PMC: 4896564. DOI: 10.4161/hv.28332.


Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test.

Lee H, Min K, Park K, Choi H, Kim M, Ahn C J Microbiol. 2014; 52(5):435-40.

PMID: 24610332 PMC: 7090846. DOI: 10.1007/s12275-014-3529-y.